March 3, 2020 / 11:24 AM / a month ago

BRIEF-Neuronetics Reports Q4 And Full Year 2019 Financial Results

March 3 (Reuters) - Neuronetics Inc:

* NEURONETICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL AND OPERATING RESULTS

* Q4 LOSS PER SHARE $0.41

* Q4 REVENUE $17.4 MILLION VERSUS REFINITIV IBES ESTIMATE OF $16.9 MILLION

* Q4 EARNINGS PER SHARE ESTIMATE $-0.44 — REFINITIV IBES DATA

* NEURONETICS - FOR FULL YEAR 2020, CO EXPECTS TO REPORT TOTAL WORLDWIDE REVENUE BETWEEN $69.0 AND $71.0 MILLION

* NEURONETICS - FOR FULL YEAR 2020, CO EXPECTS GROSS MARGINS TO BE IN MID 70% RANGE, IN LINE WITH FULL YEAR 2019 MARGINS

* NEURONETICS - FOR FULL YEAR 2020, CO EXPECTS OPERATING EXPENSES TO BE BETWEEN $76.0 AND $78.0 MILLION

* NEURONETICS - CASH AND CASH EQUIVALENTS WERE $75.7 MILLION AS OF DEC 31, 2019

* NEURONETICS - FOURTH QUARTER 2019 U.S. TREATMENT SESSION REVENUE OF $11.2 MILLION, AN INCREASE OF 13% OVER FOURTH QUARTER OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below